Animal Cell Line Modification

Background of Animal Cell Line Modification

Animal cells are widely used in biotechnology for the production of therapeutic proteins. Genetic engineering of animal cells allows for the modification of cellular processes and the production of recombinant proteins with specific properties.

The background of CD Biosynsis in animal cell line modification includes gene editing using CRISPR/Cas9 technology, gene knockdown using siRNA, gene overexpression using viral vectors or plasmids, and cell line development for the expression of specific proteins. We use cutting-edge technologies to modify animal cells for the production of therapeutic proteins, such as insulin and growth factors. Our services are designed to provide high-quality results, customized solutions, and comprehensive services to meet the needs of our clients.

Figure 1. Current focus areas of innovative research in industrial cell line development. (Tihanyi B., Nyitray L. et al. 2020)

Services offering

Genetic Engineering of CHO Cells Modification

Recombinant Protein Expression in CHO Cells

Genetic Manipulation of HEK Cells Modification

Viral Vector Production in HEK Cells

Advantages of Partnering with CD Biosynsis

• High-quality results: We use advanced techniques and high-quality materials to ensure that our services produce the desired results.
• Customized solutions: We work closely with our clients to understand their specific needs and develop customized solutions that meet their requirements.
• Comprehensive services: We offer a range of services, including gene editing, gene knockdown, gene overexpression, and cell line development, to provide a comprehensive solution for our clients.
• Fast turnaround times: We have a fast turnaround time of 2-4 weeks for gene editing and gene knockdown services, and 4-6 weeks for gene overexpression and cell line development services.

Want to Learn More

If you are interested in learning more about our services for animal cell line modification, please contact us. We will be happy to provide you with more information and answer any questions you may have.

Reference

1. Tihanyi B., Nyitray L. Recent advances in CHO cell line development for recombinant protein production. Drug Discovery Today: Technologies, 2020, 38: 25-34.

Please note that all services are for research use only. Not intended for any clinical use.